Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enteroendocrine L-cells are specialized hormone-secreting cells distributed throughout the gastrointestinal epithelium, most densely in the distal small intestine and colon[1][4][7]. They sense nutrients and release anorectic peptides such as glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), which regulate satiety, glucose homeostasis, and metabolism. L-cells have site-specific heterogeneity in peptide expression and responsiveness, and may be subclassified (e.g., proximal vs distal) based on anatomical site and function[4][9]. L-cells are a research focus for metabolic disease, but drugs target the hormones they secrete or their differentiation, not the cells themselves[9].
Nutrient-dependent GLP-1 and PYY secretion induces *insulin release* (GLP-1 effect), appetite suppression (GLP-1, PYY), and slows gastric emptying Drugs may act by stimulating L-cell differentiation or hormone secretion
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enteroendocrine L-cell (L-cell).